Cargando…
Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial
BACKGROUND: Thrice-weekly haemodialysis is the usual dose when starting renal replacement therapy; however, this schedule is no longer appropriate since it does not consider residual renal function. Several reports have suggested the potential benefit of beginning haemodialysis less frequently and i...
Autores principales: | Fernández Lucas, M., Ruíz-Roso, G., Merino, J. L., Sánchez, R., Bouarich, H., Herrero, J. A., Muriel, A., Zamora, J., Collado, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031943/ https://www.ncbi.nlm.nih.gov/pubmed/32075665 http://dx.doi.org/10.1186/s13063-020-4058-0 |
Ejemplares similares
-
Residual renal function in incremental haemodialysis
por: Vartia, Aarne
Publicado: (2018) -
Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis
por: Caton, Emma, et al.
Publicado: (2022) -
Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial
por: Kaja Kamal, Raja Mohammed, et al.
Publicado: (2020) -
Outcomes of incident patients treated with incremental haemodialysis as compared with standard haemodialysis and peritoneal dialysis
por: Jaques, David A, et al.
Publicado: (2022) -
Proteomic analysis of plasma proteins of high-flux haemodialysis and on-line haemodiafiltration patients reveals differences in transthyretin levels related with anaemia
por: Martínez-Alonso, Emma, et al.
Publicado: (2020)